Aktuellt
SENASTE
Redeye saw sales roughly in line with our expectations in the Q1 report, as deliveries of Carbonhand were made in the quarter. The costs was starting to trend lower as per the cost-cutting program. The fact that Carbonhand is now registered as a 510(k) by FDA opens up for sales in the US earlier than expected.
LÄS MER
